Mulberry Biotherapeutics, Inc. — Form D
Mulberry Biotherapeutics, Inc. of WELLESLEY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-30. The offering totals $2.8M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-04-30
- Form: D
- Accession: 0001859602-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.8M
- Amount sold: $2.1M
- Remaining: $686K
- Investors: 17
- Date of first sale: 2021-04-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-397742
Issuer
- Name: Mulberry Biotherapeutics, Inc.
- CIK: 0001859602
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 40 WALNUT STREET, SUITE 301, WELLESLEY, MA, 02481
- Phone: 617-800-3415
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Philip R Reilly | Director | Wellesley, MA |
| Neil R Kirby | Executive Officer | Wellesley, MA |
| Susan Luo | Executive Officer | Wellesley, MA |
More